These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35898322)

  • 21. Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease.
    Grau-Rivera O; Navalpotro-Gomez I; Sánchez-Benavides G; Suárez-Calvet M; Milà-Alomà M; Arenaza-Urquijo EM; Salvadó G; Sala-Vila A; Shekari M; González-de-Echávarri JM; Minguillón C; Niñerola-Baizán A; Perissinotti A; Simon M; Kollmorgen G; Zetterberg H; Blennow K; Gispert JD; Molinuevo JL;
    Alzheimers Res Ther; 2021 Feb; 13(1):46. PubMed ID: 33597012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy.
    Svenningsson AL; Stomrud E; Palmqvist S; Hansson O; Ossenkoppele R
    Alzheimers Res Ther; 2022 Oct; 14(1):144. PubMed ID: 36192766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF biomarkers in Olmsted County: Evidence of 2 subclasses and associations with demographics.
    Van Harten AC; Wiste HJ; Weigand SD; Mielke MM; Kremers WK; Eichenlaub U; Batrla-Utermann R; Dyer RB; Algeciras-Schimnich A; Knopman DS; Jack CR; Petersen RC
    Neurology; 2020 Jul; 95(3):e256-e267. PubMed ID: 32591471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.
    Racine AM; Koscik RL; Nicholas CR; Clark LR; Okonkwo OC; Oh JM; Hillmer AT; Murali D; Barnhart TE; Betthauser TJ; Gallagher CL; Rowley HA; Dowling NM; Asthana S; Bendlin BB; Blennow K; Zetterberg H; Carlsson CM; Christian BT; Johnson SC
    Alzheimers Dement (Amst); 2016; 2():27-38. PubMed ID: 26955655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
    Olsson B; Lautner R; Andreasson U; Öhrfelt A; Portelius E; Bjerke M; Hölttä M; Rosén C; Olsson C; Strobel G; Wu E; Dakin K; Petzold M; Blennow K; Zetterberg H
    Lancet Neurol; 2016 Jun; 15(7):673-684. PubMed ID: 27068280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study.
    Dhiman K; Villemagne VL; Fowler C; Bourgeat P; Li QX; Collins S; Bush AI; Rowe CC; Masters CL; Ames D; Blennow K; Zetterberg H; Martins RN; Gupta V
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults.
    Blackman J; Stankeviciute L; Arenaza-Urquijo EM; Suárez-Calvet M; Sánchez-Benavides G; Vilor-Tejedor N; Iranzo A; Molinuevo JL; Gispert JD; Coulthard E; Grau-Rivera O;
    Brain Commun; 2022; 4(6):fcac257. PubMed ID: 36337343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples.
    Skillbäck T; Zetterberg H; Blennow K; Mattsson N
    Alzheimers Res Ther; 2013 Oct; 5(5):47. PubMed ID: 24479774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Giacomucci G; Mazzeo S; Bagnoli S; Ingannato A; Leccese D; Berti V; Padiglioni S; Galdo G; Ferrari C; Sorbi S; Bessi V; Nacmias B
    J Neurol; 2022 Aug; 269(8):4270-4280. PubMed ID: 35288777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individuals.
    Alemany S; Crous-Bou M; Vilor-Tejedor N; Milà-Alomà M; Suárez-Calvet M; Salvadó G; Cirach M; Arenaza-Urquijo EM; Sanchez-Benavides G; Grau-Rivera O; Minguillon C; Fauria K; Kollmorgen G; Domingo Gispert J; Gascón M; Nieuwenhuijsen M; Zetterberg H; Blennow K; Sunyer J; Luis Molinuevo J;
    Environ Int; 2021 Dec; 157():106864. PubMed ID: 34537521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
    Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
    Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers.
    Novobilský R; Bartova P; Lichá K; Bar M; Stejskal D; Kusnierova P
    Front Hum Neurosci; 2023; 17():1284416. PubMed ID: 38164192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg.
    Dittrich A; Ashton NJ; Zetterberg H; Blennow K; Zettergren A; Simrén J; Skillbäck T; Shams S; Machado A; Westman E; Schöll M; Skoog I; Kern S
    Neurology; 2023 Jul; 101(3):e277-e288. PubMed ID: 37225431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Biomarkers for Alzheimer's Disease: Plasma Neurofilament Light and Cerebrospinal Fluid.
    Abukuri DN
    Int J Alzheimers Dis; 2024; 2024():6668159. PubMed ID: 38779175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dynamics of plasma biomarkers across the Alzheimer's continuum.
    Guo Y; Shen XN; Wang HF; Chen SD; Zhang YR; Chen SF; Cui M; Cheng W; Dong Q; Ma T; Yu JT
    Alzheimers Res Ther; 2023 Feb; 15(1):31. PubMed ID: 36750875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.
    Mielke MM; Przybelski SA; Lesnick TG; Kern S; Zetterberg H; Blennow K; Knopman DS; Graff-Radford J; Petersen RC; Jack CR; Vemuri P
    Alzheimers Dement; 2021 May; 17(5):801-812. PubMed ID: 33663022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly.
    Shue F; White LJ; Hendrix R; Ulrich J; Henson RL; Knight W; Martens YA; Wang N; Roy B; Starling SC; Ren Y; Xiong C; Asmann YW; Syrjanen JA; Vassilaki M; Mielke MM; Timsina J; Sung YJ; Cruchaga C; Holtzman DM; Bu G; Petersen RC; Heckman MG; Kanekiyo T
    Sci Adv; 2024 Apr; 10(14):eadk3674. PubMed ID: 38569027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.
    Tideman P; Stomrud E; Leuzy A; Mattsson-Carlgren N; Palmqvist S; Hansson O;
    Neurology; 2022 Apr; 98(15):e1525-e1533. PubMed ID: 35022305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.